Digital Therapeutics: the future of healthcare is happening now
In this interview, Megan Coder, Founder of the Digital Therapeutics Alliance[i] (DTA) and Chief Policy Officer, shares her insights about how Digital Therapeutics (DTx) – an innovative and evidence-based treatment – can improve patients’ health outcomes. Megan draws on her clinical training as a pharmacist to explain more about digital therapeutics and their extensive, exciting benefits for patients and healthcare practitioners. She explains how DTx work, why she set up the DTA and how success for her means improving clinical and health outcomes for patients by making this a go-to option